BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

SurgiQuest Announces First Single Port Procedure for Ovary Removal Using AirSeal(TM) Access System


5/7/2008 7:31:07 AM

ORANGE, Conn., May 7 /PRNewswire/ -- SurgiQuest, Inc. today announced the first single port laparoscopic removal of an ovary using the AirSeal(TM) access system.

Drs. Anthony Discuillo and Christopher Awtry performed the procedure at Mount Auburn Hospital in Cambridge, MA. The AirSeal System creates an invisible barrier that does not rely on gaskets or seals. This provides unobstructed access to the cavity without loosing intra-abdominal pressure, enabling surgeons to place a telescope, all operative instruments and large specimen sac through a single 12mm port.

"The AirSeal Access System represented a significant improvement in operative management of patients with adnexal masses, which traditionally requires three separate ports for completion," said Dr. Awtry, Instructor of Gynecological Oncology at Harvard Medical School. "The five centimeter mass was worrisome for malignancy. After it was removed from the pelvic sidewall, we were able to place it in a sac and remove it without spillage."

Dr. Discuillo, Assistant Professor of Obstetrics and Gynecology at Harvard School of Medicine added, "The successful completion of our case represents a paradigm shift in the way we will perform major gynecologic procedures in the future. This is truly a revolutionary technology that allows us to perform complex operations with only one small abdominal incision in the belly button."

"Gynecology represents an important and large segment of the minimally invasive marketplace," said Kurt Azarbarzin, Founder and CEO of SurgiQuest. "The first clinical experience with the AirSeal access system in this specialty is an important milestone for SurgiQuest. We are pleased Drs. Discuillo and Awtry were able to take advantage of the AirSeal system to perform this operation safely and effectively while eliminating the risks and additional patient care associated with two additional trocars."

About the AirSeal(TM) access system:

The AirSeal(TM) access system presents a significant technological shift in minimally invasive surgery (MIS). By eliminating seals and gaskets from access ports, the AirSeal system provides unobstructed access to the abdominal cavity without loosing intra-abdominal pressure. This unencumbered approach to MIS is enabling both new procedure development and new instrument platforms.

SurgiQuest, Inc. is a private venture-backed company, founded in May 2006. It develops, manufactures, and markets access technology for minimally invasive surgery.

CONTACT: Timothy J. Nolan, Vice President, Marketing and Sales,
+1-203-799-2400, for SurgiQuest, Inc.

Web site: http://www.surgiquest.com/


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->